Colic Clinical Trial - Parecoxib in Renal Colic

Status Terminated

Clinical Trial Summary

This is a phase III, multicenter, randomized, single blind study designed to evaluate the efficacy and tolerability of a single dose of parecoxib compared with diclofenac in the treatment of acute pain due to renal colic.

Clinical Trial Description

This study was prematurely discontinued May 3, 2004 due to slow recruitment. The decision to terminate the trial was not based on any safety concerns. ;

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind, Primary Purpose: Treatment

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT00139646
Study type	Interventional
Source	Pfizer
Contact
Status	Terminated
Phase	Phase 3
Start date	April 2002
Completion date	April 2004

View Details

See also
Status	Clinical Trial	Phase
Completed	`NCT01849991` - Safety and Effect of L. Reuteri on Biomarkers of Inflammation in Healthy Infants With Colic	Phase 1
Completed	`NCT01279265` - Effect of Lactobacillus Rhamnosus GG (LGG) on Infant Colic	N/A
Completed	`NCT00177086` - Alfuzosin Hydrochloride to Promote Passage of Distal Ureteral Calculi	Phase 3
Not yet recruiting	`NCT02577133` - Prevention of Colic With the Probiotic Lactobacillus Reuteri	Phase 2/Phase 3
Recruiting	`NCT01715220` - Treatment of Suspected Cholelithiasis With Nitroglycerin	Phase 2
Completed	`NCT00922727` - Safety of Lactobacillus Reuteri (L. Reuteri) in Healthy Adults	Phase 1
Completed	`NCT02865564` - Effect of Lactobacillus Reuteri DSM17938 in Neonates Treated With Antibiotics	N/A
Completed	`NCT01997593` - Peritoneal Ropivacaine Infiltration on Postoperative Pain in Children Affected	Phase 2
Completed	`NCT01541046` - Lactobacillus Reuteri DSM 17938 Versus Placebo in the Treatment of Infantile Colic	Phase 2
Completed	`NCT00929292` - Safety and Tolerance Study of Alpha-Lactalbumin Enriched and Probiotic-Supplemented Infant Formula in Infants With Colic	Phase 3
Terminated	`NCT05554991` - Human Milk Oligosaccharide (HMO) Supplementation in Colic Management	N/A
Recruiting	`NCT01067027` - Control of Colic in Infants by Dietary Supplementation With the Probiotic Lactobacillus Reuteri	Phase 4
Recruiting	`NCT04983069` - Neonatal Outcome of Children With Antenatal Colic Hyperechogenicity
Recruiting	`NCT05685030` - Probiotics Strains for Infant Colic	Phase 2
Withdrawn	`NCT05198700` - The Effect of Probiotics on Symptoms of Infantile Colic	Phase 2
Terminated	`NCT02586558` - Effect of a Prebiotic on Colic and Crying and Fussing Behaviour in Infants	N/A
Completed	`NCT01532518` - Preliminary Efficacy, Safety and Pharmacokinetics Study of Nepadutant in Infant With Feeding Intolerance	Phase 2
Completed	`NCT00796523` - An Intervention to Decrease Infant Crying	N/A
Completed	`NCT05052476` - First Line Dose-efficacy Study of Bactecal® D Liquid for Infant Colic	N/A
Completed	`NCT02242292` - Study to Evaluate Efficacy and Safety of Oral Doses of Hyoscine Butylbromide for the Treatment of Occasional Abdominal Pain, Cramping, and Discomfort	Phase 2